Sheng-Yu Chen MD.

Hematology and Oncology

SPECIALTY/PRACTICE AREAS：
• Hematology: Anemia, thrombocytopenia, Leukopenia, hematological malignancies.
• Oncology: Head and neck cancer, esophageal cancer, breast cancer, gastric cancer, pancreatic cancer, colon cancer, target therapy, immunotherapy.
LANGUAGES SPOKEN：
• English
• Chinese

 

PROFESSIONAL EDUCATION：

• School of Medicine, Taipei Medical University

 

ADMINSTRATIVE APPOINTMENTS：

• Attending physician, Cancer Center, Veterans General Hosptial-Taipei, Taiwan, ROC.
• Visiting scholar, Medical oncology, City of Hope National Medical Center, U.S.A.
• Chief, Division of Hemato-Oncology, Internal Medicine, Taipei Medical University Hospital, Taiwan, ROC

 

Certification and Licensure：

• National Board of Medicine, ROC.
• Board of Internal Medicine, ROC.
• Board of Hematology, ROC.
• Board of Medical Oncology, ROC.
• Board of Hospice Palliative Medicine, ROC.

 

PUBLICATIONS：

• Chi KH, Chen CH, Chan WK, Chow KC, Chen SY, Yen SH, Chao JY, Chen KY: Effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients after cisplatin, fluorouracil, and leucovorin chemotherapy. J Clin Oncol 13:2620-2628, 1995.
• Chi KH, Chan WK, Shu CH, Law CK, Chen SY, Yen SH, Chen KY: Elimination of dose limiting toxicities of cisplatin, 5-fluorouracil, and leucovorin using a weekly 24-hour infusion schedule for the treatment of patients with nasopharyngeal carcinoma. Cancer 76:2186-2192, 1995.
• Chen SY, Liang LL, Chang SL, Meng ML, Yen SH, Low CK, Chi KH, Chen KY: Outpatient continuous infusional chemotherapy with ambulatory infusional pump- the early experience of outpatient chemotherapy unit at the veterans general hospital-Taipei. Therapeu Radiol Oncol 5: 19-25, 1998.
• Wu LJ, Chen KY, Chi KH, Chen SY, Liang MJ, Shiau CY, Wang LW, Liu YM, Chow KC, and Yen SH. The significance of soluble interleukin-2 receptor in monitoring disease relapse in patients with nasopharyngeal cancer. Jpn J Clin Oncol 28: 729-732, 1998.
• Chen SY, Zhou BS, He FQ, and Yen Y. Inhibition of human cancer cell growth by inducible expression of human ribonucleotide reductase antisense cDNA. Antisense and nucleic acid drug development 10: 111-116, 2000.